Rock Springs Capital Management LP Viking Therapeutics, Inc. Transaction History

Rock Springs Capital Management LP

  • $3.22 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$17.4 - $94.5 $4.54 Million - $24.7 Million
261,000 New
261,000 $21.4 Million
Q4 2018

Feb 14, 2019
SELL
$7.16 - $16.21 $1.43 Million - $3.24 Million
-200,000 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$9.7 - $19.65 $1.94 Million - $3.93 Million
200,000 New
200,000 $3.48 Million

Others Institutions Holding VKTX

# of Institutions
478
Shares Held
66.1M
Call Options Held
6.24M
Put Options Held
3.01M
View Full List

About Viking Therapeutics, Inc.

VKTX Quotes by TradingView
  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $5.05B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Rock Springs Capital Management LP Portfolio

Follow Rock Springs Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email